Lilac pharma Inc. 

Lilac pharma is looking for a EU partner for Commercial agreement regarding a new lipid nanoparticle production device.

KEY ACTIVITIES Drug and drug development
SECTOR: Biotech & Life science / Pharmaceutical / Nanotechnology
KEY WORDS: Lipid nanoparticle, Liposome, Micelle
TYPE OF ACTIVITIES Research collaboration/ R&D cooperation / Services / Manufacturing / Technology Transfer

Company Activity Description:

 

We are now dealing with a new lipid nanoparticle production device, “iLiNP”

- Easy to manipulate. Run a solution only.

- Easy to produce liposomes with homogeneous size.

- Easy to change the size peak between 20 and 150nm.

- Easy to modulate the size only by flux control.

- Easy to scale up by parallel configuration.

 

Type of Partnership Sought:

1.Commercial agreement with technical assistance
2.License agreement
3.Joint venture

 

Additional information:

The iLiNP device; overview

 

DevicePreparation condition

  iLiNP standard

Input

  Inlet 1 : Ethanol + lipid

  Inlet 2 : Water

 

 

Information of partnership sought

1. Commercial agreement with technical assistance

Lilac licenses-out the patent(s) and know-hows regarding the iLiNP device. The Licensee launches a CRO business (Liposome-manufacturing service) using the iLiNP device.

2. License agreement

Lilac licenses-out the patent(s) and know-hows regarding the iLiNP device. The licensee uses the iLiNP device for in-house R&D and manufacturing of drugs.

3. Joint Venture

Launch a CRO business (Liposome manufacturing service) using the iLiNP device by joint-venture basis.